Simplex Trading’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31
Closed -$151 10080
2025
Q4
$144 Sell
31
-995
-97% -$4.51K ﹤0.01% 8279
2025
Q3
$4K Buy
+1,026
New +$3.53K ﹤0.01% 8439
2023
Q3
Sell
-190
Closed 9744
2023
Q2
$0 Buy
+190
New +$859 ﹤0.01% 9880

Other funds holding SOPH

Simplex Trading's SOPH Position: Q1 2026 in Review

Simplex Trading sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 31 shares — an estimated $151 sold.

Simplex Trading first reported a position in SOPH in Q2 2023 and held it in 3 quarters. The position peaked at $4K in Q3 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Simplex Trading reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 31 SOPHiA GENETICS shares in Q1 2026, an estimated $151.
  • Simplex Trading first reported a position in SOPHiA GENETICS in Q2 2023 and held it in 3 quarters.
  • Simplex Trading's SOPHiA GENETICS position peaked at $4K in Q3 2025.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.